Primary systemic amyloidosis: A brief overview.
Hughes MS, Lentzsch S.
Presse Med. 2025 Mar;54(1):104267. doi: 10.1016/j.lpm.2024.104267. Epub 2024 Dec 11.
Systemic Light Chain Amyloidosis.
Sanchorawala V.
N Engl J Med. 2024 Jun 27;390(24):2295-2307. doi: 10.1056/NEJMra2304088.
Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Ruberg FL, Maurer MS.
JAMA. 2024 Mar 5;331(9):778-791. doi: 10.1001/jama.2024.0442.
Primary Systemic Amyloidosis.
Zhang Y, Feng L.
J Cutan Med Surg. 2022 Sep-Oct;26(5):541. doi: 10.1177/12034754211064314. Epub 2021 Dec 8.
Primary Systemic Amyloidosis: A Case Report.
Oli SS, Jha A, Karki A, Sapkota S, Adhikari L.
JNMA J Nepal Med Assoc. 2023 Oct 1;61(266):822-824. doi: 10.31729/jnma.8297.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators.
N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631.
Primary systemic amyloidosis.
EISEN HN.
Am J Med. 1946 Aug;1:144-60. doi: 10.1016/0002-9343(46)90032-0.
[MOTOR NEUROPATHY PRECEDING PRIMARY SYSTEMIC AMYLOIDOSIS].
Mermelstein M, Benninger F, Tamir I.
Harefuah. 2024 Jul;163(7):419-422.
Systemic Light Chain Amyloidosis.
Dudzinski DM, Pellikka PA.
N Engl J Med. 2024 Sep 26;391(12):1165. doi: 10.1056/NEJMc2409196.
Hepatocyte Growth Factor and Primary Systemic Amyloidosis.
Karasuyama T, Honma Y, Kumamoto K, Shibata M, Watanabe T, Shimajiri S, Abe S, Yamashita T, Harada M.
J UOEH. 2021;43(2):227-233. doi: 10.7888/juoeh.43.227.
